Conatus Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Conatus Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-706,560	Closed	-$86M	–	23
2014 Q3	$86M	Sell	706,560 -480,641	-40%	-$58.4M	3.68%	16
2014 Q2	$140M	Hold	1,187,201	–	–	6.46%	4
2014 Q1	$143M	Sell	1,187,201 -146,400	-11%	-$17.4M	6.32%	4
2013 Q4	$148M	Sell	1,333,601 -86,218	-6%	-$8.57M	5.58%	3
2013 Q3	$131M	Buy	1,419,819 +956,443	+206%	+$86.5M	5.52%	3
2013 Q2	$39.2M	Buy	+463,376	New	+$38.6M	1.64%	36

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Conatus Capital Management's TMO Position: Q4 2014 in Review

Conatus Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2014, closing a stake of 706,560 shares — an estimated $86M sold.

Conatus Capital Management first reported a position in TMO in Q2 2013 and held it in 6 quarters. The position peaked at $148M in Q4 2013. 961 funds tracked by Wall St. Rank hold TMO as of Q4 2014.

Conatus Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2014 after selling out during the quarter.
Conatus Capital Management sold 706,560 Thermo Fisher Scientific shares in Q4 2014, an estimated $86M.
Conatus Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 6 quarters.
Conatus Capital Management's Thermo Fisher Scientific position peaked at $148M in Q4 2013.
961 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2014.

Based on Conatus Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.